An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for Patients with Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations

Jan 18, 2023

Home » Publications » Published 2023 » Page 4 Chouaid, C., Bosquet, L., Girard, N. et al. An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for Patients with Advanced Non-Small Cell Lung Cancer...

Second primary cancer risks for female and male breast cancer survivors

Nov 16, 2022

Home » NDRS » Page 6 Isaac Allen; Tameera Rahman; Andrew Bacon; Craig Knott; Sophie Jose; Sally Vernon; Hend Hassan; Catherine Huntley; Lucy Loong; Yvonne Walburga; Katrina Lavelle; Eva Morris; Steven Hardy; Beth Torr; Diana Eccles; Clare Turnbull; Marc...

Artificial Intelligence in Drug Design: Opportunities and Challenges

Nov 4, 2021

Home » Archives for Rosemarie Gant » Page 19 Thomas M, Boardman A, Garcia-Ortegon M, Yang H, de Graaf C, Bender AMethods in Molecular Biology (MIMB, volume 2390) https://link.springer.com/protocol/10.1007/978-1-0716-1787-8_1 Abstract: Artificial intelligence (AI) has...